These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 38955861

  • 1. Immune checkpoint inhibitors-induced diabetes mellitus (review).
    Chen J, Hou X, Yang Y, Wang C, Zhou J, Miao J, Gong F, Ge F, Chen W.
    Endocrine; 2024 Nov; 86(2):451-458. PubMed ID: 38955861
    [Abstract] [Full Text] [Related]

  • 2. Case report: Strong GAD antibody positivity and type 1 diabetes-HLA-susceptible haplotype-DRB1*04:05-DQB1*04:01 in a Japanese patient with immune checkpoint inhibitor-induced type 1 diabetes.
    Yabuki S, Hirai H, Moriya C, Kusano Y, Hasegawa T.
    Front Endocrinol (Lausanne); 2024 Nov; 15():1407192. PubMed ID: 38841300
    [Abstract] [Full Text] [Related]

  • 3. Rare, late onset of immune checkpoint inhibitor-induced type 1 diabetes mellitus in a patient with small-cell lung cancer treated with serplulimab: a case report and review of the literature.
    Ning P, Liu S, Cao H.
    J Med Case Rep; 2024 Jan 22; 18(1):51. PubMed ID: 38247005
    [Abstract] [Full Text] [Related]

  • 4. Incidence of diabetes mellitus in patients treated with immune checkpoint inhibitors (ICI) therapy - A comprehensive cancer center experience.
    Zhang Z, Sharma R, Hamad L, Riebandt G, Attwood K.
    Diabetes Res Clin Pract; 2023 Aug 22; 202():110776. PubMed ID: 37311494
    [Abstract] [Full Text] [Related]

  • 5. [Immune Checkpoint Inhibitors Related Diabetes Mellitus: 
A Report of 2 Cases and Literature Review].
    Ren Y, Zhang L, Wang Y, Zhong D.
    Zhongguo Fei Ai Za Zhi; 2022 Jan 20; 25(1):61-65. PubMed ID: 35078286
    [Abstract] [Full Text] [Related]

  • 6. Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice.
    Cho YK, Jung CH.
    Diabetes Metab J; 2023 Nov 20; 47(6):757-766. PubMed ID: 37482654
    [Abstract] [Full Text] [Related]

  • 7. Recent advances in immune checkpoint inhibitor-induced type 1 diabetes mellitus.
    Liao D, Liu C, Chen S, Liu F, Li W, Shangguan D, Shi Y.
    Int Immunopharmacol; 2023 Sep 20; 122():110414. PubMed ID: 37390646
    [Abstract] [Full Text] [Related]

  • 8. Type 1 diabetes related to immune checkpoint inhibitors.
    Tachibana M, Imagawa A.
    Best Pract Res Clin Endocrinol Metab; 2022 May 20; 36(3):101657. PubMed ID: 35450793
    [Abstract] [Full Text] [Related]

  • 9. Type 1 diabetes associated with immune checkpoint inhibitors for malignant melanoma: A case report and review of 8 cases.
    Ishiguro A, Ogata D, Ohashi K, Hiki K, Yamakawa K, Jinnai S, Tsutsui K, Takahashi A, Namikawa K, Yamazaki N.
    Medicine (Baltimore); 2022 Sep 02; 101(35):e30398. PubMed ID: 36107581
    [Abstract] [Full Text] [Related]

  • 10. Combined diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 1 diabetes mellitus induced by immune checkpoint inhibitors: Underrecognized and underreported emergency in ICIs-DM.
    Zhang W, Chen J, Bi J, Ding N, Chen X, Wang Z, Jiao Y.
    Front Endocrinol (Lausanne); 2022 Sep 02; 13():1084441. PubMed ID: 36686495
    [Abstract] [Full Text] [Related]

  • 11. [IMMUNE CHECKPOINT INHIBITOR-INDUCED DIABETES MELLITUS].
    Fischer M, Amos S, Levy L, Pollack R.
    Harefuah; 2021 Oct 02; 160(10):657-662. PubMed ID: 34689435
    [Abstract] [Full Text] [Related]

  • 12. Immune Checkpoint Inhibitor-Induced Diabetes Mellitus: Potential Role of T Cells in the Underlying Mechanism.
    Mourad D, Azar NS, Eid AA, Azar ST.
    Int J Mol Sci; 2021 Feb 20; 22(4):. PubMed ID: 33672515
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immune Checkpoint Inhibitors-Associated Diabetes and Ketoacidosis Were Found in FDA Adverse Event Reporting System: A Real-World Evidence Database Study.
    Han M, Jiang L, Zhao B, Liu X, Yang C, Chen W.
    Endocr Pract; 2024 Sep 20; 30(9):887-892. PubMed ID: 38876180
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pembrolizumab induced type 1 diabetes mellitus in a patient with metastatic melanoma and literature review on steroids as a treatment option.
    Greene A, Penner S, Kunesh J, Altaf A, McGrade W, Niu J.
    J Oncol Pharm Pract; 2024 Sep 20; 30(6):1084-1088. PubMed ID: 38544442
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside.
    Wu L, Tsang VHM, Sasson SC, Menzies AM, Carlino MS, Brown DA, Clifton-Bligh R, Gunton JE.
    Front Endocrinol (Lausanne); 2021 Sep 20; 12():764138. PubMed ID: 34803927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.